CHU de Quebec Université LavalQuebec, QC, Canada
Rheumatologist with an interest in inflammatory myopathies
1161: Proteasome Inhibitor Repurposed for Dermatomyositis: Results of a Drug Repurposing Analysis Based on the Transcriptomic Signature of Patients' Perifascicular Fibers Validated in Pre-clinical Models
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.
